AB
Ankush Bhan
About Ankush Bhan
Data last updated:
Ankush Bhan is a Designated Partner at Syphen Lifesciences Llp (since 2025). The companies operate in Pharma. Earlier, Ankush Bhan was a Director at Rizer Healthcare Private Limited (2004–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Syphen Lifesciences Llp ACP-7053 | Designated Partner | 05 Jul 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Rizer Healthcare Private Limited U24239DL2004PTC124929 | Director | 15 Jun 2004 | 2004 | ₹18 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ankush Bhan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kapil Kumar Silaveni | 11186875 | Syphen Lifesciences Llp | Designated Partner |
| Namisha Kaul | 07709667 | Syphen Lifesciences Llp | Designated Partner |
| Pankaj Singh | 11186874 | Syphen Lifesciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankush Bhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankush Bhan
Ankush Bhan currently holds 1 directorship: Syphen Lifesciences Llp (Designated Partner, since 05 Jul 2025).
Ankush Bhan was first appointed on 15 Jun 2004 as Director at Rizer Healthcare Private Limited. The most recent appointment on record is 05 Jul 2025 at Syphen Lifesciences Llp.
Ankush Bhan held 1 earlier board appointment: Rizer Healthcare Private Limited (Director, 15 Jun 2004 to 28 Feb 2018).
The current boards of Ankush Bhan's companies include Kapil Kumar Silaveni (Syphen Lifesciences Llp), Namisha Kaul (Syphen Lifesciences Llp), Pankaj Singh (Syphen Lifesciences Llp).